Suppr超能文献

米格列醇对正常及非胰岛素依赖型糖尿病大鼠碳水化合物消化和肠道代谢影响的体外研究

In vitro study of the effect of miglitol on carbohydrate digestion and intestinal metabolism in normal and non-insulin-dependent diabetic rats.

作者信息

Tormo M A, Ropero M F, Nieto M, Martinez I M, Campillo J E

机构信息

Departamento de Fisiología, Facultad de Medicina, Universidad de Extremadura, Badajoz, Spain.

出版信息

Can J Physiol Pharmacol. 1996 Nov;74(11):1196-203. doi: 10.1139/cjpp-74-11-1196.

Abstract

The effect of miglitol was studied (20 mg/kg body weight), administered intraduodenally alone or together with maltose, on the absorption and intestinal metabolism of glucose during its translocation from the lumen of the intestine to the blood, using in vitro perfused preparations of complete small intestine-pancreas, proximal small intestine alone, or distal small intestine alone, isolated from normal and non-insulin-dependent diabetic rats. In the absence of a luminal administration of maltose in normal rats, the glucose uptake from the vascular perfusate was greater in the presence (0.52 +/- 0.04 mmol/h) than in the absence (0.39 +/- 0.02 mmol/h) of miglitol (p < 0.05). In diabetic rats, no significant variations were observed in glucose uptake from the vascular perfusate as an effect of miglitol, but the glucose uptake in the presence of this drug was significantly less (p < 0.05) than that observed in normal rats. Portal lactate was significantly greater (p < 0.05) in diabetic than in normal rats and, after administration of miglitol, rose in both normal and diabetic rats, the rise being significantly greater in normal than in diabetic rats (p < 0.01). When maltose was administered luminally (2 g/kg body weight), the values of portal glucose in both normal and diabetic rats were significantly less in the presence of miglitol in the complete as well as in the distal and proximal small intestine preparations (p < 0.05); the glucose uptake from luminal administered maltose was greater in the presence of miglitol in diabetic (p < 0.05) and in normal (p < 0.05) rats except in the complete small intestine of normal rats; and no significant differences were observed in portal lactate levels between normal and diabetic rats in the presence of miglitol. In conclusion, our results show that miglitol administered luminally at the doses employed here, as well as reducing the transport of glucose from the lumen of the intestine into the blood supply, significantly stimulate intestinal glucose metabolism.

摘要

研究了米格列醇(20毫克/千克体重)经十二指肠单独给药或与麦芽糖一起给药,对葡萄糖从肠腔转运至血液过程中的吸收及肠道代谢的影响,实验采用从正常大鼠和非胰岛素依赖型糖尿病大鼠分离出的完整小肠 - 胰腺、单独的近端小肠或单独的远端小肠的体外灌注制剂。在正常大鼠中,若肠腔未给予麦芽糖,存在米格列醇时血管灌注液中葡萄糖摄取量(0.52±0.04毫摩尔/小时)高于不存在米格列醇时(0.39±0.02毫摩尔/小时)(p<0.05)。在糖尿病大鼠中,作为米格列醇作用的结果,血管灌注液中葡萄糖摄取未观察到显著变化,但该药物存在时的葡萄糖摄取量显著低于正常大鼠(p<0.05)。糖尿病大鼠门静脉乳酸水平显著高于正常大鼠(p<0.05),给予米格列醇后,正常大鼠和糖尿病大鼠的门静脉乳酸水平均上升,但正常大鼠的上升幅度显著大于糖尿病大鼠(p<0.01)。当经肠腔给予麦芽糖(2克/千克体重)时,在完整小肠以及远端和近端小肠制剂中,正常大鼠和糖尿病大鼠在米格列醇存在时门静脉葡萄糖值均显著降低(p<0.05);除正常大鼠完整小肠外,糖尿病大鼠(p<0.05)和正常大鼠(p<0.05)在米格列醇存在时从肠腔给予的麦芽糖中摄取的葡萄糖更多;在米格列醇存在时,正常大鼠和糖尿病大鼠门静脉乳酸水平未观察到显著差异。总之,我们的结果表明,在此处使用的剂量下经肠腔给予米格列醇,除了减少葡萄糖从肠腔向血液供应的转运外,还显著刺激肠道葡萄糖代谢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验